Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 12 Mar 21 424B4 Prospectus supplement with pricing info
- 12 Mar 21 EFFECT Notice of effectiveness
-
8 Mar 21 S-1/A IPO registration (amended)
- 19 Feb 21 S-1 IPO registration
LBPH similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
The Board of Directors
Longboard Pharmaceuticals, Inc.:
We consent to the use of our report dated February 19, 2021, except as to the March Forward Stock Split described in Note 1, which is as of March 8, 2021, with respect to the balance sheet of Longboard Pharmaceuticals, Inc. as of December 31, 2020, the related statements of operations and comprehensive loss, convertible preferred stock and stockholders’ deficit, and cash flows for the period January 3, 2020 (inception) through December 31, 2020, and the related notes, included herein and to the reference to our firm under the heading “Experts” in the prospectus.
/s/ KPMG LLP
San Diego, California
March 8, 2021